Results 1 to 10 of about 28,197 (214)
First identification of novel NDM carbapenemase, NDM-7, in Escherichia coli in France. [PDF]
BACKGROUND: The NDM-1 carbapenemase has been identified in 2008 in Enterobacteriaceae. Since then, several reports have emphasized its rapid dissemination throughout the world.
Gaelle Cuzon +2 more
doaj +5 more sources
Production of Plasmid-Encoding NDM-1 in Clinical Raoultella ornithinolytica and Leclercia adecarboxylata From China [PDF]
Raoultella ornithinolytica YNKP001 and Leclercia adecarboxylata P10164, harboring conjugative plasmids pYNKP001-NDM and pP10164-NDM with determination of complete nucleotide sequences, respectively, were isolated from two different Chinese patients ...
Fengjun Sun, Peiyuan Xia, Dongsheng Zhou
exaly +4 more sources
Polyclonal Dissemination of NDM-1- and NDM-9-Producing Escherichia coli and Klebsiella pneumoniae in French Polynesia. [PDF]
The whole-genome sequencing analysis revealed a polyclonal dissemination of NDM-1 and NDM-9 variants in Escherichia coli ( n = 20) and Klebsiella pneumoniae ( n = 2) in Tahiti since 2015 via interspecies transfer of three different
Laurent Dortet +2 more
exaly +3 more sources
Carbapenem-resistant Klebsiella pneumoniae (CRKP), which harbors the bla NDM plasmid, has been reported extensively and is considered a global threat clinically.
Yunxing Yang, Darong Duan, Longjie Zhou
exaly +3 more sources
Covalent inhibition of New Delhi metallo-β-lactamases NDM-1 and NDM-5 by 3-bromopyruvate. [PDF]
Abstract Objectives Resistance to β-lactam antibiotics, including carbapenems, mediated by metallo-β-lactamases (MBLs), including the New Delhi metallo-β-lactamase (NDM) family, is increasing. No MBL inhibitors are currently approved for clinical use, with most reported MBL inhibitors acting as
Bradley JK +7 more
europepmc +3 more sources
New Delhi, an enzyme belonging to the Metallo-beta-lactamases and Carbapenemases group, is most commonly found in Klebsiella pneumoniae and Escherichia coli. It determines these bacteria resistance to the majority of known antibiotics.
Kamil Leis +13 more
doaj +8 more sources
Inhibition of the NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome has recently emerged as a promising therapeutic target for several inflammatory diseases.
Sohaib Nizami +9 more
doaj +1 more source
Antibiotic-resistance genes in E. coli strains in GCC countries: A meta-analysis
Background: Antimicrobial resistance (AMR) in Escherichia coli is an alarming issue worldwide, including in the Gulf Cooperation Council (GCC) countries, yet the prevailing gene patterns have not recently been reviewed.
Khalid Mubarak Bindayna +3 more
doaj +1 more source
Antimicrobial resistance has emerged as a major danger to contemporary medicine around the world. Carbapenems are the highest class of B-lactam drugs which are considered as the most effective and safest antibiotics available.
S. Abhishek +3 more
doaj +1 more source
ObjectiveMultidrug-resistant organisms (MDRO), especially carbapenem-resistant organisms (CRO), represent a threat for newborns. This study investigates the colonization prevalence of these pathogens in a newborn unit at a Kenyan tertiary hospital in an ...
David Villinger +19 more
doaj +1 more source

